Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Open-market sale Chief Scientific Officer sold 19,475 shares at an average $40.36 ($786,061)
  2. 4 Grant or award Director acquired 4,443 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale SVP, Diagnostics, immunoSEQ Dx sold 16,052 shares at an average $43.58 ($699,560)
  5. 4 Open-market sale CEO and Chairman sold 15,000 shares at an average $42.89 ($643,416)
  6. 4 Grant or award Director acquired 4,443 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Director sold 6,000 shares at an average $43.06 ($258,363)
  9. 4 Open-market sale Chief Business Development Off sold 1,354 shares at an average $41.69 ($56,451)
  10. 4 Open-market sale Chief People Officer sold 2,000 shares at an average $41.83 ($83,656)
  11. 8-K Event Executive or director change · Regulation FD disclosure
  12. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $42.54 ($425,400)
  13. 4 Open-market sale Director sold 806,000 shares at an average $39.99 ($32,228,827)
  14. 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $40.24 ($402,425)
  15. 4/A Open-market sale Director sold 20,000 shares at $57.80 ($1,156,000)
  16. 4 Open-market sale Director sold 2,000 shares at $44.56 ($89,120)
  17. 4 Open-market sale Director sold 2,000 shares at $44.56 ($89,120)
  18. 4 Grant or award Chief Medical Officer acquired 22,894 shares (grant or award)
  19. 4 Grant or award President acquired 45,788 shares (grant or award)
  20. 4 Grant or award Chief Scientific Officer acquired 68,681 shares (grant or award)

Page 24 of 42 · 837 filings